Gleevec
Novartis rides out fiscal hardship to beat Q3 forecasts
October 25, 2016Manufacturing and Production, Sales and Marketing Entresto, Gleevec, Novartis
Novartis has beaten its third-quarter sales projections, announcing that new product growth and cost cuts managed to carry the company …
Sun Pharma takes on Novartis in the US with generic Glivec
February 2, 2016Manufacturing and Production, Research and Development, Sales and Marketing Gleevec, Novartis, Sun Pharma
Mumbai-based drug manufacturer Sun Pharma has launched a generic version of Glivec, for the same indications for which the former …
Lilly and Novartis face legal challenges
June 25, 2015Medical Communications, Sales and Marketing Gleevec, Glivec, Novartis, cymbalta, imatinib, lilly, zyprexa
Judges in California have ruled that Lilly should face claims it failed to fully disclose the extent of post-withdrawal side …
Novartis sales below forecast in ‘transformative’ year
January 28, 2015Sales and Marketing Diovan, Exforge, Gleevec, Jimenez, Novartis, amlodipine, q4, valsartan
Novartis’ fourth quarter sales have faded slightly as growth in pharmaceuticals is beaten back by generic competition, and the firm …
Novartis agrees Gleevec patent deal
May 19, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Gleevec, India, Novartis, Sun Pharma, patent
Novartis has settled patent litigation with Sun Pharmaceutical Industries in the US, paving the way for the Indian company’s subsidiary …
Novartis reports healthy profit
April 25, 2014Sales and Marketing Afinitor, Gleevec, Glivec, Novartis, Q1, lilly
Multiple sclerosis drug Gilenya and cancer treatment Afinitor were among the biggest sellers for Novartis, as the Swiss company’s net …
Sales rise for Novartis
January 30, 2014Sales and Marketing Gleevec, Glivec, Novartis, gilenya, q4, sales
Multiple sclerosis drug Gilenya, with sales rising 62% year-on-year to $1.9 billion, was one of the stars of last year …
Glivec cleared for longer use in GIST patients
February 28, 2012Sales and Marketing Europe, GIST, Gleevec, Glivec, Novartis
Glivec has gained EU approval for extended use after surgery for adults with KIT (CD117)-positive gastrointestinal stromal tumours (GIST).The drug …
Trial hitch for Pfizer’s leukaemia drug submission plans
December 7, 2010Research and Development, Sales and Marketing CML, Gleevec, Glivec, Pfizer, bosutinib, chronic myeloid leukaemia
Pfizer is pressing ahead with plans to submit bosutinib for European approval despite the chronic myeloid leukaemia drug missing its …
Latest content
